- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chemotherapy and inflammatory conditions
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 395KB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 73KB)
Methotrexate – July 2024
Methotrexate; Tablet 2.5 mg (as sodium), Tablet 10 mg (as sodium); Methoblastin®
Last updated
30 May 2025